Jump to content
RemedySpot.com

Medline Article on Glutathione Depletion and CFIDS

Rate this topic


Guest guest

Recommended Posts

Med Hypotheses 1999 Oct;53(4):347-9

Competition for glutathione precursors between the immune system and the

skeletal muscle: pathogenesis of chronic fatigue syndrome.

Bounous G, Molson J

Department of Surgery, McGill University, and Medical Research Council

of Canada.

[Medline record in process]

The chronic fatigue syndrome (CFS) is typically associated or follows a

recognized or presumed infection. Abnormalities of both humoral and

cellular immunity have been demonstrated in a substantial proportion of

patients with CFS. The most consistent findings are of impaired

lymphocyte responses to mitogen. As an antioxidant, glutathione (GSH) is

essential for allowing the lymphocyte to express its full potential

without being hampered by oxiradical accumulation. Hence, protracted

challenge of the immunocytes may lead to cellular GSH depletion. Because

GSH is also essential to aerobic muscular contraction, an undesirable

competition for GSH precursors between the immune and muscular systems

may develop. It is conceivable that the priority of the immune system

for the survival of the host has drawn to this vital area the

ever-diminishing GSH precursors, thus depriving the skeletal muscle of

adequate GSH precursors to sustain a normal aerobic metabolism resulting

in fatigue and eventually myalgia.

PMID: 10608272, UI: 20073951

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...